13Dec 2024
ROX Index Predicts HFNC/NIV Failure in Severe COVID-19

ROX Index Predicts HFNC/NIV Failure in Severe COVID-19

The respiratory rate-oxygenation (ROX) index has shown promise in predicting the need for intubation in patients with acute respiratory failure. This retrospective cohort study evaluated its performance in predicting failure of alternating high-flow nasal cannula (HFNC) and noninvasive ventilation (NIV) in severe COVID-19 patients. Among 105 ICU patients, 47% required orotracheal intubation (OTI) within 7 days. A ROX index <4.88 at 2 hours of NIV initiation was associated with a higher risk of failure (HR: 1.90, 95% CI: 1.03-3.51, p = 0.039). The area under the ROC curve was 0.702, with an optimal cut-off value of 5.22, offering 71.4% sensitivity and 63.3% specificity. These findings highlight the ROX index as a useful tool for early identification of HFNC/NIV failure in severe COVID-19.

  • #critical care

Like

Save

Share